This special FAQ episode brings together Dr. Dennis Kim, Hematologist/Oncologist, and Dr. Gizelle Popradi, Hematologist, for an in-depth conversation on what clinicians need to know about cGVHD management.

Our experts offer an insightful overview of the evolving frontline algorithm in cGVHD management, including how to select patients for systemic steroids and when to reassess for non-response. They highlight how emerging therapeutic agents are shaping sequential treatment decisions and provide practical guidance on multidisciplinary care and proactive monitoring for multi-organ involvement and early pulmonary changes. The experts also emphasize the importance of incorporating patient-reported outcomes into clinical practice.

Tune in to explore  ...